DTRA

Clinical ink CBO Jonathan Andrus Selected as DTRA Co-Leader Chosen to Head Decentralized Trials & Research Alliance Regulatory Gap Initiative

Press Release / , ,

Clinical ink CBO Jonathan Andrus Selected as DTRA Co-Leader Chosen to Head Decentralized Trials & Research Alliance Regulatory Gap Initiative Horsham, Pa.; August 12, 2021 […]

Clinical ink CBO Jonathan Andrus Selected as DTRA Co-Leader Chosen to Head Decentralized Trials & Research Alliance Regulatory Gap Initiative Read More...

McKesson Ventures Invests as Clinical ink Debuts Lunexis ePRO+ Solution Mixed Modalities Allow Users to Switch Between Smartphones, Tablets, and Web Any Time

Press Release / , ,

HORSHAM, Pa.; Dec. 3, 2020 – Clinical ink, a global clinical trial technology company, today announced an investment from McKesson Ventures alongside its significantly enhanced electronic patient reported outcome (ePRO) module. Lunexis™ ePRO+ is part of a unified

McKesson Ventures Invests as Clinical ink Debuts Lunexis ePRO+ Solution Mixed Modalities Allow Users to Switch Between Smartphones, Tablets, and Web Any Time Read More...

Linkedin-in Youtube

Discover eSource

Get to Know Us

Reach Out

Sales and Solutions
Direct      1.336.464.0697

Support
Toll-Free 1.800.301.5033
Direct      1.336.464.0697

Insert HTML text here.

Scroll to Top

Contact Clinical ink

Request more information, submit questions, set up a demonstration, and more.